Prevalence of skin disease in HIV-positive pregnant women
✍ Scribed by Norma Alonso; Aída Lugo-Somolinos; Damaris Torres-Paoli; Jorge L. Sánchez
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 76 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0011-9059
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background The rate of human immunodeficiency virus (HIV) infection in women of reproductive age has increased dramatically in the last decade. The effects of pregnancy on the prevalence of cutaneous diseases in this group is unclear.
Objectives To compare the prevalence of cutaneous diseases in healthy pregnant women, HIV‐positive pregnant women, and HIV‐positive nonpregnant women.
Methods Fifty HIV‐positive pregnant women and 52 HIV‐positive nonpregnant women were compared with a control group of 50 HIV‐negative pregnant women for the prevalence of cutaneous diseases.
Results The prevalence of cutaneous diseases was higher (65%) in the HIV‐positive nonpregnant group than in the HIV‐positive pregnant group (42%) or the control group (28%). Infectious diseases were more frequent in the HIV‐positive nonpregnant group.
Conclusions Pregnancy does not seem to increase the prevalence of cutaneous diseases that occur during the course of HIV disease.
📜 SIMILAR VOLUMES
## Abstract A retrospective survey estimating the prevalence of hepatitis viruses B (HBV) and C (HCV) was conducted on samples taken in 1,002 African pregnant women (501 diagnosed as HIV‐1 positive and 501 HIV‐1 negative) participating in a clinical trial program conducted in Abidjan, Côte d'Ivoire
## Abstract GB virus C (GBV‐C) is an apathogenic virus that has been shown to inhibit HIV replication. This study examined the prevalence and correlates of GBV‐C infection and clearance in three cohorts of pregnant women in Thailand. The study population consisted of 1,719 (1,387 HIV‐infected and 3
One-hundred-ninety-three pregnant and seventy five non-pregnant women, aged 18-35 years, were examined for endocervical infection with Chlamydia trachomatis using an enzyme immunoassay technique on cervical specimens. Chlamydia trachomatis was discovered in 7.2% of the pregnant women and in 10.6% of
## Abstract Hepatitis E virus, a cause of sporadic hepatitis in developed countries is present in Spain. The aims of this study were to determine whether the prevalence of IgG anti‐hepatitis E virus antibodies has increased in recent years in Spain and the prevalence in a study population at risk o
The prevalence of infections which have deleterious effects to either the mother or the fetus during pregnancy are unknown in Cameroon. To formulate appropriate antenatal screening policies for the Central Mother and Child Clinic in Yaounde, we tested random sera obtained from 1,014 stored samples p